Apontis Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Apontis Pharma has a total shareholder equity of €30.3M and total debt of €6.0M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are €57.5M and €27.2M respectively.
Key information
19.9%
Debt to equity ratio
€6.02m
Debt
| Interest coverage ratio | n/a |
| Cash | €26.82m |
| Equity | €30.26m |
| Total liabilities | €27.20m |
| Total assets | €57.46m |
Recent financial health updates
Recent updates
Potential Upside For Apontis Pharma AG (ETR:APPH) Not Without Risk
Apr 05
We Think Apontis Pharma (ETR:APPH) Can Afford To Drive Business Growth
Dec 02Not Many Are Piling Into Apontis Pharma AG (ETR:APPH) Stock Yet As It Plummets 27%
Jul 29Apontis Pharma's (ETR:APPH) Robust Earnings Are Supported By Other Strong Factors
Apr 08Financial Position Analysis
Short Term Liabilities: APPH's short term assets (€35.1M) exceed its short term liabilities (€23.3M).
Long Term Liabilities: APPH's short term assets (€35.1M) exceed its long term liabilities (€3.9M).
Debt to Equity History and Analysis
Debt Level: APPH has more cash than its total debt.
Reducing Debt: APPH's debt to equity ratio has reduced from 176.9% to 19.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APPH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if APPH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.